PD Dr. Markus Hecht

Medizinische Fakultät Department of Radiation Oncology

First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC (2019) Lettmaier S, Hecht M, Fietkau R Conference contribution Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? (2019) Onbasi Y, Lettmaier S, Hecht M, Semrau S, Iro H, Kesting MR, Fietkau R, Haderlein M Journal article Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - High locoregional control rates after photon (chemo) radiotherapy - Experience from a monocentric analysis (2019) Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Putz F, Iro H, et al. Journal article Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer (2019) Fietkau R, Hecht M, Hofner B, Iro H, Gefeller O, Roedel C, Hautmann M, et al. Conference contribution Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? (2019) Onbasi Y, Lettmaier S, Hecht M, Semrau S, Iro H, Kesting MR, Fietkau R, Haderlein M Journal article Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study (2018) Hecht M, Hahn D, Wolber P, Hautmann M, Reichert D, Weniger J, Belka C, et al. Conference contribution Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI) (2018) Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, et al. Conference contribution Radiosensitizing and radioprotecting effect of kinase-inhibitor Palbociclib in different normal tissue and cancer cell lines (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Kinase Inhibitor Palbociclib shows differential Effects upon Irradiation on Normal Tissue and Cancer Cell Lines (2018) Jost T, Proebstle S, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Repeating of local therapy of distant metastases increases overall survival in patients with synchronous metastasized rectal cancer-a monocentric analysis (2018) Haderlein M, Lettmaier S, Langheinrich M, Schmid A, Semrau S, Hecht M, Beck M, et al. Journal article